Novo Nordisk A/S
Prognozy (mln)
Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
Przychód (średnia) |
286,122.16 |
358,928.55 |
392,046.41 |
429,886.98 |
461,848.37 |
499,902.16 |
Przychód Δ r/r |
0.00% |
25.45% |
9.23% |
9.65% |
7.43% |
8.24% |
Przychód (min) |
281,033.32 |
349,192.16 |
377,541.38 |
394,172.33 |
423,478.39 |
458,370.69 |
Przychód (max) |
291,211.01 |
368,664.93 |
406,551.44 |
474,409.91 |
509,681.50 |
551,676.47 |
EBITDA (średnia) |
132,449.84 |
166,152.91 |
181,483.61 |
199,000.53 |
213,795.89 |
231,411.50 |
EBIT (średnia) |
121,775.05 |
152,761.81 |
166,856.94 |
182,962.08 |
196,565.01 |
212,760.90 |
EBIT % |
42.56% |
42.56% |
42.56% |
42.56% |
42.56% |
42.56% |
Zysk netto (średni) |
100,796.27 |
127,355.50 |
141,322.77 |
156,170.28 |
178,904.18 |
200,670.67 |
Zysk netto % |
35.23% |
35.48% |
36.05% |
36.33% |
38.74% |
40.14% |
EPS (średnia) |
22.58 |
28.54 |
31.67 |
34.99 |
40.09 |
44.96 |
Liczba analityków (Przychody) |
13 |
12 |
11 |
5 |
4 |
5 |
Liczba analityków (EPS) |
4 |
5 |
6 |
2 |
3 |
4 |
symbol |
NVO |
NVO |
NVO |
NVO |
NVO |
NVO |